PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Pradaxa
Presentation Product Chemical substance Chapter Items dispensed
Pradaxa 150mg capsules
0208020X0BBACAC
Pradaxa Dabigatran etexilate Cardiovascular System 937
Pradaxa 110mg capsules
0208020X0BBABAB
Pradaxa Dabigatran etexilate Cardiovascular System 835
Pradaxa 75mg capsules
0208020X0BBAAAA
Pradaxa Dabigatran etexilate Cardiovascular System 18
Pradaxa 20mg granules sachets
0208020X0BBADAD
Pradaxa Dabigatran etexilate Cardiovascular System 1
Pradaxa 110mg granules sachets
0208020X0BBAHAH
Pradaxa Dabigatran etexilate Cardiovascular System No data available
Pradaxa 150mg granules sachets
0208020X0BBAIAI
Pradaxa Dabigatran etexilate Cardiovascular System No data available
Pradaxa 30mg granules sachets
0208020X0BBAEAE
Pradaxa Dabigatran etexilate Cardiovascular System No data available
Pradaxa 40mg granules sachets
0208020X0BBAFAF
Pradaxa Dabigatran etexilate Cardiovascular System No data available
Pradaxa 50mg granules sachets
0208020X0BBAGAG
Pradaxa Dabigatran etexilate Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.